Mitozolomide-induced sensitisation of mammalian cells in vitro to radiation
1989
Mitozolomide and Radiation Sensitization
publication
Evidence: moderate
Author Information
Author(s): M.J. McKeagel, P.B. Roberts
Primary Institution: Wellington Hospital, New Zealand
Hypothesis
Does mitozolomide enhance radiation damage in mammalian cells?
Conclusion
Mitozolomide has the potential to enhance radiation damage, but the effect is modest and time-dependent.
Supporting Evidence
- Mitozolomide treatment reduced the fraction of viable cells significantly.
- Cells treated with mitozolomide were more sensitive to radiation than untreated controls.
- The enhancement effect was observed when radiation exposure followed drug treatment by 4-12 hours.
Takeaway
Mitozolomide might help make cancer cells more sensitive to radiation, but it works best if given a few hours before the radiation treatment.
Methodology
Chinese hamster ovary cells were treated with mitozolomide and then irradiated to assess survival rates.
Limitations
The study primarily involved in vitro experiments, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.005
Confidence Interval
95%
Statistical Significance
p<0.005
Want to read the original?
Access the complete publication on the publisher's website